Cargando…

Pink1(−/−) rats are a useful tool to study early Parkinson disease

Detalles Bibliográficos
Autores principales:	Kelm-Nelson, Cynthia A, Lechner, Sarah A, Lettenberger, , Samantha E, Kaldenberg, Taylor A R, Pahapill, , Natalie K, Regenbaum, , Amy, Ciucci, Michelle R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066864/ https://www.ncbi.nlm.nih.gov/pubmed/33928251 http://dx.doi.org/10.1093/braincomms/fcab077

Ejemplares similares

Predictors of prodromal Parkinson’s disease in young adult Pink1−/− rats
por: Lechner, Sarah A., et al.
Publicado: (2022)

Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease
por: Stevenson, Sharon A., et al.
Publicado: (2019)

Data in support of qPCR primer design and verification in a Pink1 −/− rat model of Parkinson disease
por: Kelm-Nelson, Cynthia A., et al.
Publicado: (2016)

Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease
por: Glass, Tiffany J., et al.
Publicado: (2020)

Prodromal Parkinson disease signs are predicted by a whole-blood inflammatory transcriptional signature in young Pink1−/− rats
por: Lechner, Sarah A., et al.
Publicado: (2023)

Gene expression within the periaqueductal gray is linked to vocal behavior and early-onset parkinsonism in Pink1 knockout rats
por: Kelm-Nelson, Cynthia A., et al.
Publicado: (2020)

Rat Models of Vocal Deficits in Parkinson’s Disease
por: Krasko, Maryann N., et al.
Publicado: (2021)

The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010)

Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats
por: Lamberty, Benjamin G., et al.
Publicado: (2023)

Pink hypopyon in a patient with Serratia marcescens corneal ulceration
por: Stefater, James A, et al.
Publicado: (2015)

Enhancing NAD(+) salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease
por: Lehmann, Susann, et al.
Publicado: (2016)

Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
por: Abramov, Andrey Yurevich, et al.
Publicado: (2011)

Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011)

To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s disease
por: de Haas, Ria, et al.
Publicado: (2019)

Outlook of PINK1/Parkin signaling in molecular etiology of Parkinson’s disease, with insights into Pink1 knockout models
por: Wang, Zhangting, et al.
Publicado: (2023)

Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson’s Disease and Pink1 Knockout Rats
por: Salvatore, Michael F., et al.
Publicado: (2022)

Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
por: Gandhi, Sonia, et al.
Publicado: (2012)

Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
por: Blagov, Alexander V., et al.
Publicado: (2022)

T313M polymorphism of the PINK1 gene in Parkinson’s disease
por: LUO, QIN, et al.
Publicado: (2014)

Structure of PINK1 and mechanisms of Parkinson's disease-associated mutations
por: Kumar, Atul, et al.
Publicado: (2017)

Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson’s Disease
por: Vizziello, Maria, et al.
Publicado: (2021)

PINK1: A Bridge between Mitochondria and Parkinson’s Disease
por: Gonçalves, Filipa Barroso, et al.
Publicado: (2021)

Increased cysteine metabolism in PINK1 models of Parkinson's disease
por: Travaglio, Marco, et al.
Publicado: (2023)

Parkinson’s Disease: Are PINK1 Activators Inching Closer to the Clinic?
por: Mehellou, Youcef
Publicado: (2023)

PINK1: From Parkinson’s disease to mitophagy and back again
por: O’Callaghan, Benjamin, et al.
Publicado: (2023)

Effects of deep brain stimulation on vocal fold immobility in Parkinson's disease
por: Arocho-Quinones, Elsa V., et al.
Publicado: (2017)

The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
por: van der Vlag, Marc, et al.
Publicado: (2020)

Salmon pink patch sign: Diagnosing persistent fetal vasculature
por: Khokhar, Sudarshan, et al.
Publicado: (2016)

Trichloroethylene: An Invisible Cause of Parkinson’s Disease?
por: Dorsey, E. Ray, et al.
Publicado: (2023)

Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease
por: Celardo, I, et al.
Publicado: (2016)

The effects of morphine on Parkinson’s-related genes PINK1 and PARK2
por: Snyder, Christopher, et al.
Publicado: (2014)

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
por: Borsche, Max, et al.
Publicado: (2020)

Pink-beam serial crystallography
por: Meents, A., et al.
Publicado: (2017)

AB75. Lower urinary tract dysfunction in a pink1 gene knockout rat model for Parkinson’s disease
por: Lin, Guiting
Publicado: (2014)

Low thymine content in PINK1 mRNAs and insights into Parkinson’s disease
por: Anandagopu, Perumal, et al.
Publicado: (2010)

New Perception of Mitochondrial Regulatory Pathway in Parkinsonism – Ubiquitin, PINK1, and Parkin
por: Olszewska, Diana Angelika, et al.
Publicado: (2014)

PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease
por: Kazlauskaite, Agne, et al.
Publicado: (2015)

PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
por: Mouton-Liger, Francois, et al.
Publicado: (2017)

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson’s disease
por: Trinh, Joanne, et al.
Publicado: (2022)

CRISPR/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys
por: Yang, Weili, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vgrh845d052g9rf9gs742eujhu